Pharmafile Logo
Pharmafocus logo
Advanced Search

AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders

November 7, 2025
Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders

AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …

News

Ardena appoints new Chief Quality Officer and Chief Information Officer

November 6, 2025
Ardena, CDMO, CRO, Chief Information Officer, chief quality officer

Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) and bioanalytical contract research organisation (CRO) focusing on precision medicines, …

Appointment

Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO

November 5, 2025
Draig Therapeutics, Neuropsychiatry, neuroscience

Draig Therapeutics, a Welsh clinical-stage company developing glutamate and GABA-based treatments for neuropsychiatry, has appointed Ivana Magovčević-Liebisch as President and …

Appointment

Von Willebrand disease – increasing awareness and access to vital care

November 4, 2025
Medical Communications, Research and Development European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …

Feature

Rethinking oncology trial endpoints with generalised pairwise comparisons

November 4, 2025
Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …

Feature

VALANX Biotech appoints Klaus Orlinger as Chief Scientific Officer

November 4, 2025
Antibody-Drug Conjugate, VALANX Biotech, drug development

VALANX Biotech, a company developing novel technology for site-specific protein conjugation in drug discovery, has appointed Klause Orlinger as Chief …

Appointment

The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust

November 3, 2025
Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients

Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …

Feature

Five Facts about men’s mental health

October 31, 2025
Medical Communications Five Facts, mental health, men’s mental health

1 While only 15.4% of men are diagnosed with a common mental health condition (CMHC’s) in the UK (compared to …

Feature

AAX Biotech and Daiichi Sankyo partner to evaluate antibody therapeutics

October 31, 2025
AAX Biotech, Daiichi Sankyo, Opti-mAb, Seqitope

AAX Biotech, a Swedish biotechnology company specialising in next-generation antibody therapeutics, has launched a strategic partnership with Daiichi Sankyo, a …

News
partnership

Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies

October 30, 2025
Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership

Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …

News

Is this an Oppenheimer moment for the life sciences industry?

October 29, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …

Feature
Thought Leadership
drug-trials

Pharma&’s ovarian cancer therapy approved for use by NHS Scotland

October 29, 2025
Pharma&, Rubraca, Scottish Medicines Consortium, nhs scotland, oncology, ovarian cancer

Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by the Scottish Medicines Consortium (SMC) …

News

BioMedX launches R&D accelerator to advance women’s health

October 28, 2025
Research and Development BioMedX, Gates Foundation, Women’s Health

BioMed X, an independent research institute with sites in Germany and the United States, has announced the launch of XFem …

News

Berlin Heals appoints Dr Eric Fain as new board member

October 28, 2025
Berlin Heals, Cardiovascular Health, chronic heart failure, medtech

Berlin Heals, a clinical-stage medical device company focused on treating chronic heart failure, has appointed Dr Eric S Fain to …

Appointment

Turning a 10-Year Vision into a 10-Year Plan

October 27, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …

Feature

Sharp invests $100m in US and EU manufacturing and packaging facilities

October 27, 2025
Manufacturing and Production EU, Sharp Services, US, manufacturing and packaging

Sharp Services, a pharmaceutical packaging and sterile manufacturing specialist, has announced investments totalling $100m across its US and European facility …

News
partnership

NNIT partners with global biopharma company for regulatory registration management

October 24, 2025
Business Services IT, NNIT, digital solutions, regulatory

NNIT, a Danish provider of digital software and IT services, has entered a long-term strategic partnership with a global biopharmaceutical …

News
drug-trials

THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment

October 23, 2025
Research and Development Neurological Diseases, THX Pharma, Theranexus

THX Pharma (Theranexus), a pharma company focusing on developing treatments for rare neurological disease, and Exeltis, a pharma company within …

News

Excellence in Healthcare Partnerships (EHP) Awards Networking Event

October 23, 2025
Medical Communications EHP Awards

From plan to partnership: navigating the enablers and challenges of collaborative working. How has the 10-year healthcare plan and Life …

News
handshake-2056023_960_720

PolyNovo welcomes Bruce Peatey as CEO

October 22, 2025
CEO, Market Expansion, PolyNovo, medtech, wound care

PolyNovo, an Australian medtech company specialising in acute complex wound management, has appointed Bruce Peatey as its new chief executive …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026